Doctors raise alarm over H. pylori drug resistance
Medical professionals in Tanzania are reporting increased drug resistance in Helicobacter pylori infections, leading to treatment failures for many patients. Experts emphasize the necessity of proper diagnosis and avoiding self-medication to combat this growing public health challenge.
Why it matters
Antibiotic resistance is a critical global health threat that complicates the treatment of common bacterial infections.
Dar es Salaam. For some patients, treating Helicobacter pylori (H. pylori) is no longer a straightforward process, with doctors reporting cases in which commonly used medicines fail to clear the infection.
The bacterium, which can cause inflammation of the stomach lining, peptic ulcers and, in the long term, increase the risk of stomach cancer, is common in Tanzania and many other parts of the world.
Its symptoms, including stomach pain, bloating, heartburn and nausea, are increasingly being reported by patients seeking medical care.
Health experts, however, are concerned about possible antibiotic resistance, which can make standard treatment less effective and leave patients experiencing recurring symptoms.
For Jeremiah Isdory, the problem returned twice within six months despite treatment for peptic ulcers.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in